Pharming Group (PHAR) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Pharming Group Price Target Raised to EUR 2.15 From EUR 1.60 at RBC Capital
TipRanksDec 19 12:00 ET
Analysts Are Bullish on These Healthcare Stocks: Viridian Therapeutics (VRDN), Pharming Group (PHAR)
TipRanksDec 16 10:30 ET · Ratings
Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)
SECDec 16 06:13 ET · Announcements
Pharming Group Commences Cash Offer to Acquire Abliva for $66.1 Million
MT NewswiresDec 16 03:44 ET
Press Release: Pharming Announces Public Cash Offer to the Shareholders of Abliva AB
Dow JonesDec 15 13:45 ET
RBC Capital Remains a Buy on Pharming Group (PHGUF)
TipRanksDec 12 20:51 ET · Ratings

Comments

Stock_Drift

Dec 11 04:16

Pre Market Ticks 5:14am 12/11

$Sportsman's Warehouse (SPWH.US)$ $Pharming Group (PHAR.US)$ $BioXcel Therapeutics (BTAI.US)$ $Gaxos.ai (GXAI.US)$ $Rigetti Computing (RGTI.US)$ $Quantum (QMCO.US)$ $MIND Technology (MIND.US)$ $Stitch Fix (SFIX.US)$ $Frequency Electronics (FEIM.US)$ $CleanCore Solutions (ZONE.US)$ $Silexion Therapeutics (SLXN.US)$ $SEALSQ Corp (LAES.US)$
📊⚡️📊

5

1

Teddy123

Oct 10 00:28

Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation

$Pharming Group (PHAR.US)$
Leiden, the Netherlands, October 10, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces the start of a Phase II, proof of concept, clinical trial evaluating leniolisib in primary immunodeficiencies (PIDs) with immune dysregulation linked to altered PI3Kẟ signaling in lymphocytes.
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation | PHARM Stock News

Mooers Radar

Jul 25, 2023 19:38

Columns US Top Gap Ups and Downs on 7/25: LOGI, UL, RTX, SPOT and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Logitech International (LOGI.US)$ - up 6.9%
2. $F5 Inc (FFIV.US)$ - up 5.1%
3. $Unilever (UL.US)$ - up 3.9%
4. $Packaging Corp of America (PKG.US)$ - up 3.4%
5. $Rio Tinto (RIO.US)$ - up 2.5%
6. $GE Aerospace (GE.US)$ - up 2.5%
7. $ASE Technology (ASX.US)$ - up 2.4%
8. $Datadog (DDOG.US)$ - up 2.4...

+16

13

9

Mooers Radar

Jul 11, 2023 19:41

Columns US Top Gap Ups and Downs on 7/11: HPQ, CRM, TM, PHAR and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Zillow-A (ZG.US)$ - up 3.4%
2. $Newell Brands (NWL.US)$ - up 3.3%
3. $Etsy Inc (ETSY.US)$ - up 3.3%
4. $Zillow-C (Z.US)$ - up 3.0%
5. $Pharming Group (PHAR.US)$ - up 2.8%
6. $HP Inc (HPQ.US)$ - up 2.4%
7. $Salesforce (CRM.US)$ - up 2.1%
8. $SK Telecom (SKM.US)$ - up 1.9%
9. $Procore Technologies (PCOR.US)$ - up 1....

+15

13

11

Mooers Radar

Jun 23, 2023 19:20

Columns US Top Gap Ups and Downs on 6/23: KMX, PHAR, HMC, SONY and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $CarMax (KMX.US)$ - up 6.1%
2. $GlaxoSmithKline (GSK.US)$ - up 2.6%
3. $Fresenius Medical Care (FMS.US)$ - up 1.4%
Gap Downs
1. $Pharming Group (PHAR.US)$ - down 4.2%
2. $Woodside Energy (WDS.US)$ - down 3.6%
3. $Sasol (SSL.US)$ - down 3.3%
4. $ING Groep (ING.US)$ - down 2.8%
5. $Banco Santander (SAN.US)$ - down 2....

+10

21

3

11

PHAR Pharming Group

Trade Overview

Capital Trend

News

Comments